Published on 15 May 2024 on Insider Monkey via Yahoo Finance
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. US markets continued its strong rally in the first quarter. Robust economic data and relatively strong corporate earnings boosted the rally along with the anticipation of a soft landing of the market. The fund (Institutional Shares) appreciated 6.00% in the quarter compared to 9.50% for the Russell Midcap Growth Index and 10.56% for the S&P 500 Index. Stock selection and headwinds from the Fund’s longtime style biases led the fund to underperform in the first quarter. In addition, please check the fund’s top five holdings to know its best picks in 2024.
Baron Asset Fund featured stocks like Bio-Techne Corporation (NASDAQ:TECH) in the first quarter 2024 investor letter. Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (NASDAQ:TECH) develops and manufactures regent solutions, instruments, and services for research and clinical diagnostic markets. On May 13, 2024, Bio-Techne Corporation (NASDAQ:TECH) stock closed at $81.97 per share. One-month return of Bio-Techne Corporation (NASDAQ:TECH) was 28.06%, and its shares gained 0.04% of their value over the last 52 weeks. Bio-Techne Corporation (NASDAQ:TECH) has a market capitalization of $12.917 billion.